Jasper Bolsters Pipeline with Kira Acquisition and $132 Million Private Placement
Combined company advances KP-104 and briquilimab with cash runway through H2 2028.
/ 352 items
#XY Event-Driven Stocks↓
CareDx Shares Surge After Medicare Finalizes Transplant Testing Coverage
New policy brings clarity for kidney, heart, and lung patients.
Eli Lilly Enters Psychedelic Mental Health Space with $3.8 Billion AtaiBeckley Acquisition
Eli Lilly secures BPL-003 and other novel psychedelic-inspired treatments designed to provide rapid, long-lasting relief for treatment-resistant depression.
Novo’s Wegovy Pill Crushes Lilly’s Foundayo in Early Weight-Loss Battle
Novo Nordisk’s Wegovy pill is dominating early sales with 8x more prescriptions than Eli Lilly’s Foundayo.
Veradermics Surges on Analyst Backing and Promising Oral Hair Loss Data in Women
90% of women reported improved hair coverage with no major safety issues.
Celcuity’s Revtorpyk Gets FDA Nod, Delivering Strong Results in PIK3CA Wild-Type Breast Cancer
The new treatment, given with fulvestrant with or without palbociclib, nearly quadrupled progression-free survival versus standard therapy.